Skip to content
Rapid Palace

The Zimbabwean Government Turns Down ‘One-Sided’ American Health Aid Agreement Due to Data Concerns

Health aid image
The proposed American financial assistance would have supported programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

The nation of Zimbabwe has turned down a substantial US health deal valued at 367 million US dollars (£272m) spanning five years over Washington's insistence on confidential biological samples.

This move came to light following a government memo from December was leaked, revealing that President Emmerson Mnangagwa felt the deal was "skewed".

A government spokesperson later clarified that the US was requesting genetic material for scientific study and commercial purposes while was not willing to guarantee the benefits from future treatments.

"We will now turn to the challenging and unfortunate task of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the US had provided over $1.9bn as health assistance to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has appealed for continued dialogue to find a deal agreeable to all parties so the nation's vital HIV programme can proceed.

Broader Implications

This rejection follows a comparable case in neighbouring Kenya, where a high court suspended a related deal with the US following legal challenges were raised about the security of citizens' health data.

Since resuming office recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.

USAID had managed assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government deals to enhance transparency and responsibility.

According to reports, 16 African countries have so far agreed to similar health pacts, representing over $18.3bn of fresh investment.

Details of the Declined Agreement

The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this collaboration might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy via US-supported initiatives," Tremont added.

However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, without any equivalent promise of access to any medical innovations – such as new medicines or tests – that could be developed from that shared data," he stated.

"Put simply, our nation would provide the basic resources for scientific discovery with no assurance that the final treatments would be available to our citizens should a new health crisis arise."

Sovereignty and International Frameworks

He also noted that the American exit from the global health body and its pursuit of bilateral health agreements were disrupting systems already established through the global organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential global health emergencies.

"This framework is designed to guarantee that when a country contributes its information, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised solely by those with the resources to develop them."

These objections regarding the US deal "should not be misconstrued as hostility towards the US," he added.

"We encourage ongoing dialogue with our US partners on how future collaboration might be arranged in a way that respects the sovereignty and interests of both nations."

Health Experts Reaction

A leading public health body said it acknowledged the government's concerns, but urged that talks should continue since much of the country's Aids initiatives depended on international support.

"If specific concerns arise, including those relating to data governance or implementation frameworks, these can often be addressed via technical clarification and negotiated safeguards," the group said.

This impasse emphasises the complex challenges between receiving vital international aid and safeguarding national sovereignty in an increasingly interconnected world.

About the author

Seth Williams

Elara is a tech enthusiast and digital strategist with over a decade of experience in software development and online content creation.

Rapid Palace

Type to search articles.